Tuberculosis research (Prof. Katharina Kranzer)
-
Based in Harare, Zimbabwe, Prof. Katharina Kranzer serves as Director of the Health Research Unit Zimbabwe (THRU-Zim), part of the Biomedical Research and Training Institute (BRTI). She holds academic appointments at the London School of Hygiene & Tropical Medicine and Ludwig Maximilian University of Munich (Institute of Infectious Diseases and Tropical Medicine at the LMU University Hospital).
Her research focuses on tuberculosis (TB), antimicrobial resistance, and health systems in high-burden settings.
She co-leads the ERASE-TB study, funded by EDCTP, together with PD Dr. med. Norbert Heinrich (Institute of Infectious Diseases and Tropical Medicine, LMU University Hospital Munich). The study aims to evaluate novel diagnostic tools for early TB detection and targeted preventive treatment.
-
Research GroupProfessor Katharina KranzerLondon School of Hygiene & Tropical MedicineMikaela ColemanPostDocD;Ologiäg Hüäivguvi:m ful+vfinuyziusmi
-
Current projects (selection)
Early Risk Assessment in TB contacts by new diagnostic tests (ERASE-TB)
In the ERASE-TB (Early risk assessment in TB contacts by the use of new tests) study, the early diagnosis of developing tuberculosis in TB contacts will be established using new diagnostic assays. In 2021, the international research team began recruiting up to 2,100 contact persons with infectious pulmonary tuberculosis for the study. The study is being conducted with local partners in Tanzania, Mozambique and Zimbabwe and will be followed up for up to 2 years.
ERASE-TB Newsletter
CREATE PhD ProgrammeThe Southern Africa Research Capacity Network (SOFAR)